Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
City of Hope Medical Center
Jonsson Comprehensive Cancer Center
Toray Industries, Inc
Baylor College of Medicine
Eli Lilly and Company
Shanghai Junshi Bioscience Co., Ltd.
First Affiliated Hospital of Chongqing Medical University
Brown University
Eli Lilly and Company
Emory University
H. Lee Moffitt Cancer Center and Research Institute
Masonic Cancer Center, University of Minnesota
Mayo Clinic
City of Hope Medical Center
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
GlaxoSmithKline
M.D. Anderson Cancer Center
Mayo Clinic